These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1216093)

  • 1. Endolymphatic BCG therapy in the rabbit VX2 tumor.
    Edwards JM; O'Donnell TF; Johnson H; Rutt D; Kinmonth JB
    Surg Forum; 1975; 26():147-9. PubMed ID: 1216093
    [No Abstract]   [Full Text] [Related]  

  • 2. Endolymphatic isotope and BCG in the management of malignant melanoma.
    Edwards JM; Pheils PJ
    Aust N Z J Surg; 1978 Feb; 48(1):40-8. PubMed ID: 276347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor effects with intralymphatic delivery using bacillus Calmette-Guerin in animal models.
    Jeglum KA; Mangan C; Wheeler JE
    Cancer Drug Deliv; 1985; 2(2):127-32. PubMed ID: 4052927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intralymphatic administration of BCG-CWS in advanced malignant melanoma].
    Mannami T; Matsumi A; Ichikawa J; Kagawa S; Orita K; Motoi M
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):85-90. PubMed ID: 7184364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological aspects in the treatment of malignant melanoma].
    Cascinelli N; Vaglini M; Rovini D; Orefice S; Marolda R; Veronesi U
    Minerva Med; 1982 Apr; 73(18):1233-40. PubMed ID: 7078802
    [No Abstract]   [Full Text] [Related]  

  • 6. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of endolymphatic P32 labeled and I-131 labeled lipids in the VX2 involved lymph nodes of the rabbit.
    Lord RS; Kinmonth JB
    Am J Roentgenol Radium Ther Nucl Med; 1968 Aug; 103(4):856-62. PubMed ID: 5677567
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE; Meyer TJ; Azuma I; Zbar B
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunotherapy of metastatic cancer in guinea pigs: failure of intralesional BCG to influence the results of radical surgery.
    Hunter JT; Okuda T; Rapp HJ
    J Natl Cancer Inst; 1977 Nov; 59(5):1435-9. PubMed ID: 909107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG).
    Zbar B; Hunter JT; Rapp HJ; Canti GF
    J Natl Cancer Inst; 1978 May; 60(5):1163-8. PubMed ID: 642033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of polyoma tumor metastasis by combined unblocking and BCG treatment--correlation with induced alterations in tumor immunity status.
    Bansal SC; Sjögren HO
    Int J Cancer; 1973 Jul; 12(1):179-93. PubMed ID: 4597859
    [No Abstract]   [Full Text] [Related]  

  • 12. Endolymphatic therapy of tumours with particular reference to the VX2 tumour in lepus cuniculus.
    Edwards JM; Gimlette TM; Clapham WF; Rutt DL; Kinmonth JB
    Br J Surg; 1966 Nov; 53(11):969-78. PubMed ID: 5921451
    [No Abstract]   [Full Text] [Related]  

  • 13. Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery.
    Zbar B; Canti G; Ashley MP; Rapp HJ; Hunter JT; Ribi E
    Cancer Res; 1979 May; 39(5):1597-603. PubMed ID: 427799
    [No Abstract]   [Full Text] [Related]  

  • 14. Endolymphatic radionuclide therapy.
    Kubícek J; Vizda J; Urbanová E; Morávek F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1979; 22(2):101-14. PubMed ID: 293870
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental study on local immunochemotherapy].
    Kasuga M; Sakita M; Yamane T; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2113-21. PubMed ID: 6820889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lymphography and the possibility of tumor cell dissemination].
    Nikitina RG; Naidenov IuP; Malygina AI; Petrik VD
    Vopr Onkol; 1978; 24(5):3-6. PubMed ID: 208298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An experimental study on intralymphatic anti cancer chemotherapy].
    Ueno Y
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):50-63. PubMed ID: 6085016
    [No Abstract]   [Full Text] [Related]  

  • 20. Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities.
    Ariyan S; Kirkwood JM; Mitchell MS; Nordlund JJ; Lerner AB; Papac RJ
    Surgery; 1982 Sep; 92(3):459-63. PubMed ID: 7112396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.